Yüklüyor......
Oncogenic KRAS signalling in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is almost universally fatal. The annual number of deaths equals the number of newly diagnosed cases, despite maximal treatment. The overall 5-year survival rate of <5% has remained stubbornly unchanged over the last 30 years, despite tremendous efforts in p...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4150259/ https://ncbi.nlm.nih.gov/pubmed/24755884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.215 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|